| Issue Date | Title | Author(s) |
1 | 2020 | Brain lipid profile of early onset Tay-Sachs disease mouse model | Şengül, Tuğçe; Can, Melike; Akyıldız Demir, Seçil; Klose, C.; Surma, M.; Seyrantepe, Volkan |
2 | 2021 | Determination of therapeutic effects of multifunctional micelle-based nanocarriers on breast cancer cells | Ulu, Gizem Tuğçe ; Bayram, Nazende Nur; Abdulhadi, N.; Gurdap, S.; Isoglu, A.; Isoglu, S. D.; Baran, Yusuf |
3 | 2020 | Determination of therapeutic potential of luteolin for Philadelphia chromosome positive acute lymphoblastic leukaemia cells | Gürler, Sevim Beyza; Baran, Yusuf ; Kiraz, Yağmur |
4 | 2023 | Elimination of the B4Galnt1 gene normalizes lifespan and prevents pathology in Tay-Sachs disease mice | Seyrantepe, Volkan |
5 | 2023 | Investigating the efficacy of combined ketogenic diet and anti-inflammatory therapy in a mouse model of early-onset Tay-Sachs disease | inci, Orhan Kerim; Seyrantepe, Volkan |
6 | 2023 | Plasmonic functional assay platform for measuring single cell growth through refractive index sensing | Avcı, Meryem Beyza; Topkaya, Seda Nur; Yalçın-Özuysal, Özden ; Khademhosseini, Ali; Çetin, Arif E. |
7 | 2020 | Role of oxidative stress in the pathogenesis of Tay-Sachs disease mouse model | Ateş, Nurselin ; Başırlı, Hatice Hande; Çalışkan, Tufan Utku; Nalbant, Ayten ; Seyrantepe, Volkan |
8 | 2023 | T cell expressed microRNA-155 promotes antitumor immunity and immune checkpoint blockade responses in colon cancer through repression of Ship1 | Tang, William W.; Ekiz, H. Atakan ; Voth, Warren P.; Bauer, Kaylyn M.; Barba, Cindy; Ghazaryan, Arevik; Nelson, Morgan |
9 | 2024 | Treatment with recombinant human lysosomal ßhexosaminidase reduces GM2 accumulation in Tay-Sachs disease cells | Inci, Orhan Kerim; Leal, Andres F.; Ates, Nurselin ; Suarez, Diego; Espejo, Angela J.; Almeciga-Diaz, Carlos Javier; Seyrantepe, Volkan |